Louis Boon, Chief Scientific Officer at Bioceros
Dr. Louis Boon received his Ph.D. in Biochemistry at the University of Amsterdam. In 2003 he was one of the founders of Bioceros BV were he currently hold a position of CSO. In addition, he held positions as CSO for 4AZA Bioscience NV and for FF Pharma: he was VP Preclinical for PanGenetics BV and Tanox. Dr. Boon is author of over 280 papers in international scientific journals in the field of medical biotechnology.
Bioceros generates production cell lines and production processes for the industry and uses its proprietary CHOBC® platform and its SPOT™ and SLIM™ technologies to generate a portfolio of cell lines producing biosimilar monoclonal antibodies. He developed a complete process modulation toolbox to fit biosimilar CQAs. Currently he is also involved in development of innovative new molecular antibody entities, which now within the Polpharma Biologics group can be progressed to GMP production and clinical testing. This expertise is used for internal programs but also for clients from the market.